BETSHY

Category: Psychology

  • Trigeminal Neuralgia in the Long-Term: Bidirectional Impact on Psychological Health

    Trigeminal Neuralgia in the Long-Term: Bidirectional Impact on Psychological Health

    Trigeminal Neuralgia (TN) is a rare but devastating neuropathic condition characterised by sudden, electric shock-like episodes of excruciating facial pain distributed along the branches of the trigeminal nerve — the fifth cranial nerve, responsible for sensation across the face. The attacks are frequently triggered by the most mundane of stimuli: brushing teeth, speaking, eating, or even the touch of a gentle breeze. The severity of pain has long been described as among the most intense that human physiology is capable of producing, earning TN its well-known and historically significant designation as the “suicide disease” (Neto et al., 2025 ).

    While this label has been challenged in recent years as medical and surgical treatments have advanced, its existence is not without clinical basis. The psychological burden imposed by long-term TN is substantial, multidimensional, and — critically — profoundly underestimated within mainstream healthcare. This article examines how trigeminal neuralgia influences psychological changes over time, exploring the bidirectional relationship between chronic pain and mental health, the specific psychiatric conditions associated with TN, the risk of suicidality, the disruption to social and occupational functioning, and what the evidence recommends for integrated clinical management.

    Advertisements

    A Bidirectional Relationship: Pain and Mental Health

    The relationship between trigeminal neuralgia and psychological disorders is not unidirectional. Traditionally, the assumption has been that the pain of TN causes secondary mood changes such as depression and anxiety — a logical and intuitive proposition. However, emerging research using Mendelian randomisation analysis — a methodology that applies genetic markers to establish causal direction — has demonstrated that the relationship is in fact bidirectional: not only does TN precipitate psychiatric illness, but pre-existing mental health conditions including depression, anxiety, and insomnia also significantly increase the risk of developing TN in the first instance (Wang et al., 2025).

    A landmark 2025 study published in The Journal of Headache and Pain found that people with depression were more than twice as likely to develop TN, while insomnia and anxiety also significantly elevated TN onset risk. Conversely, carrying a diagnosis of TN increased the risk of developing anxiety by 43%, depression by 30%, and insomnia by nearly 40% (TNA, 2025). Furthermore, the study confirmed that longer disease duration and broader trigeminal nerve involvement were independently associated with increased severity of depressive, anxiety, and insomnia symptoms — underscoring a dose-response relationship between the chronicity of TN and the depth of its psychological toll (Wang et al., 2025).

    Depression: The Most Prevalent Psychological Consequence

    Depression is the most consistently documented psychological comorbidity in TN populations and one of the most clinically consequential. The mechanism is well-evidenced: chronic, unrelenting pain of the intensity characteristic of TN depletes neurochemical resources, disrupts sleep architecture, undermines the capacity for daily functioning, and progressively narrows the individual’s world — all known aetiological contributors to major depressive disorder (Wu et al., 2019). The unpredictability of TN attacks — which can occur without warning at any moment during waking hours — generates a state of sustained psychological vigilance that, over time, mirrors the cognitive and physiological features of a depressive episode.

    A systematic review published in Neurosurgery Reviews in 2025 — the first of its kind to comprehensively examine the psychological burden of TN — confirmed that TN patients carry significantly elevated rates of depressive disorders across multiple validated assessment tools, including the PHQ-9, Hamilton Depression Rating Scale, and Hospital Anxiety and Depression Scale. Critically, the review also found that surgical treatments, particularly microvascular decompression (MVD), effectively alleviated both pain and depressive symptoms, while multidisciplinary approaches combining psychological support with neurorehabilitation yielded the best overall outcomes — a finding with direct implications for how NHS services structure TN care pathways (Martinelli et al., 2025).

    Anxiety, Anticipatory Fear, and Catastrophising

    Anxiety in TN takes a form that is, in many respects, distinct from generalised anxiety disorder as it presents in the broader population. The central driver is anticipatory fear — the perpetual, hypervigilant dread of the next attack. Because TN pain is triggered by ordinary activities that cannot be permanently avoided — talking, eating, drinking, facial exposure to air — affected individuals frequently develop avoidance behaviours that progressively restrict their lives. They stop eating in public. They cease speaking unnecessarily. They avoid wind, cold, and touch with an intensity that begins to resemble phobic avoidance (Wu et al., 2019).

    Research comparing patients with TN against those with persistent idiopathic facial pain found that anxiety symptoms were significantly more elevated in the TN group, and that for individuals reporting prior trauma exposure, PTSD symptoms were also significantly greater among TN patients than comparison groups (ScienceDirect, 2025). The phenomenon of pain catastrophising — a cognitive pattern in which individuals magnify the threat value of pain, ruminate on its impact, and feel helpless in the face of it — is documented at elevated rates in TN and has been shown to independently worsen both pain perception and psychological outcomes over time (Frontiers in Neurology, 2025).

    PTSD, Trauma, and the Neurological Siege

    The conceptualisation of TN-related suffering within a trauma framework is gaining increasing traction in the clinical literature, and it is not difficult to understand why. The lived experience of TN — sudden, violent, entirely unpredictable episodes of pain that resist personal control and occur in the context of innocuous daily activities — shares structural features with the traumatic experiences that give rise to post-traumatic stress disorder. The nervous system learns to associate ordinary environmental stimuli with overwhelming threat, generating the hyperarousal, intrusive re-experiencing, and avoidance behaviours that characterise PTSD (Neto et al., 2025 ).

    Emerging evidence confirms that PTSD symptoms are measurably elevated in TN populations, particularly in those with longer disease duration, greater pain intensity, and inadequate treatment response. The systematic review by Martinelli et al. noted that sleep disorders — which are independently associated with the development and maintenance of PTSD — were among the most prevalent and underaddressed comorbidities in TN patients, creating a reinforcing cycle of neurological and psychological distress that becomes progressively more difficult to interrupt without targeted intervention (Martinelli et al., 2025).

    Suicidality: An Urgent and Under-Addressed Clinical Concern

    The designation of TN as the “suicide disease” demands honest and careful clinical scrutiny. A 2025 study conducted by researchers from Harvard Medical School and Massachusetts General Hospital — the largest study to date examining suicidality in TN — recruited 229 adults with TN and related conditions between December 2023 and January 2024. Their findings were sobering: suicidal ideation was found at clinically significant rates within the sample, and was strongly associated with high pain intensity, elevated anxiety, and severe depression (Fishbein, Bakhshaie and Greenberg, 2025). The authors concluded that suicidality is an urgent yet substantially under-addressed concern among adults with TN, and that its association with pain intensity places comprehensive psychological screening at the centre of responsible clinical management.

    Research examining psychological status in TN patients before and after surgical intervention has further identified that the risk of suicidal ideation is significantly higher in patients with atypical TN (TN2) than in those with classical TN (TN1), requiring more intensive psychological monitoring in this subgroup — and supporting the argument that indications for surgical treatment should be established with urgency in patients at elevated psychological risk (ScienceDirect, 2021). While the “suicide disease” label may now be contextually outdated given advances in surgical and pharmacological treatment, it retains clinical utility as a reminder of the severity of psychological risk that chronic, inadequately managed TN produces (Neto et al., 2025 ).

    Social Isolation, Identity, and Occupational Disruption

    Beyond the domain of discrete psychiatric diagnoses, TN exerts a pervasive and devastating influence on social functioning, personal identity, and occupational engagement. The avoidance behaviours generated by anticipatory fear — the withdrawal from eating, speaking, and social interaction — progressively erode the structures around which personal identity is built. Work becomes impossible, or severely constrained, for many individuals during active disease phases. Social relationships deteriorate under the weight of unexplained withdrawal and communicative limitation. For those who depend on speech professionally — teachers, therapists, lawyers, performers — the occupational consequences can be total and permanent (TNA, 2025).

    The psychological literature consistently identifies social isolation as both a consequence and an amplifier of chronic pain, generating a self-reinforcing cycle in which pain produces withdrawal, withdrawal reduces protective social buffering, and the absence of social support intensifies the subjective experience and psychological weight of pain. In TN, where the very act of social communication — speaking — can trigger an attack, this cycle is particularly vicious and particularly difficult to interrupt without targeted psychosocial intervention alongside physical pain management (Frontiers in Neurology, 2025).

    Treatment Implications: The Case for Multidisciplinary Care

    The weight of evidence reviewed here makes a compelling and unambiguous case for the integration of psychological support into the standard clinical management of trigeminal neuralgia. Pharmacological and surgical interventions — carbamazepine and oxcarbazepine as first-line medications, microvascular decompression as the preferred surgical option for suitable candidates — address the neurological substrate of TN pain with variable success, but do not in themselves address the psychological sequelae that accumulate across the duration of the illness (Martinelli et al., 2025).

    The systematic review by Martinelli et al. explicitly concluded that standardising psychological assessment and treatment methodologies is crucial for optimising TN management outcomes — and that multidisciplinary approaches combining psychological support with neurorehabilitation consistently yield superior results to purely biomedical approaches alone. The Trigeminal Neuralgia Association UK has similarly called for psychological therapy, pain counselling, and sleep support to be embedded as standard within TN care pathways — not optional additions, but structural components of responsible clinical provision (TNA, 2025).

    Conclusion

    Trigeminal neuralgia is not merely a condition of the face. It is a condition of the whole person — neurological in origin, but psychological in consequence, social in impact, and existential in the challenges it poses to identity, connection, and the basic quality of human experience. The long-term psychological changes it produces — depression, anxiety, anticipatory fear, PTSD-like trauma responses, suicidal ideation, social withdrawal, and occupational collapse — are not incidental features of living with chronic pain. They are clinical realities that demand clinical responses: structured, evidence-based, and delivered alongside rather than after physical pain management. Recognising TN as the biopsychosocial emergency it truly is remains one of the most important steps the clinical and research communities can take toward meaningfully improving outcomes for those who live with this condition.

    If you or someone you know is living with chronic pain and experiencing thoughts of suicide or self-harm, please contact the Samaritans on 116 123 (free, 24/7 in the UK) or speak to your GP or local NHS mental health service as soon as possible. If you are seeking help from outside the UK, call your local support service.

    References

    Fishbein, N.S., Bakhshaie, J. and Greenberg, J. (2025) ‘Suicidal Ideation and Self-Injury in Trigeminal Neuralgia’, Journal of Pain Research, 18, pp. 2003–2010. Available at: https://www.dovepress.com/suicidal-ideation-and-self-injury-in-trigeminal-neuralgia-peer-reviewed-fulltext-article-JPR (Accessed: 10 June 2026).

    Frontiers in Neurology (2025) ‘Effects of risk factor-based targeted nursing intervention on psychological status, sleep quality, and pain in patients with trigeminal neuralgia’, Frontiers in Neurology. Available at: https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2025.1681364/full (Accessed: 10 June 2026).

    Martinelli, R., Vannuccini, S., Burattini, B., D’Alessandris, Q.G., D’Ercole, M., Izzo, A., Chieffo, D.P.R., Doglietto, F. and Montano, N. (2025) ‘Psychological assessment in patients affected by trigeminal neuralgia: a systematic review’, Neurosurgery Reviews, 48(1), 414. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12069416/ (Accessed: 10 June 2026).

    Neto, R., Fonseca Silva, B., Remelhe, M. and Araujo, R. (2025) ‘Trigeminal Neuralgia — rethinking the “suicide disease” label’, European Psychiatry. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12438733/ (Accessed: 10 June 2026).

    ScienceDirect (2021) ‘Psychological status before and after surgery in patients with trigeminal neuralgia’, Journal of Clinical Neuroscience. Available at: https://www.sciencedirect.com/science/article/abs/pii/S0303846721001050 (Accessed: 10 June 2026).

    ScienceDirect (2025) ‘Psychological profiles and sleep quality differences between patients with persistent idiopathic facial pain and trigeminal neuralgia: a 7-year retrospective study’, Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. Available at: https://www.sciencedirect.com/science/article/abs/pii/S2212440325007746 (Accessed: 10 June 2026).

    Trigeminal Neuralgia Association UK (2025) Trigeminal Neuralgia and Mental Health. Available at: https://www.tna.org.uk/ceo/trigeminal-neuralgia-and-mental-health/ (Accessed: 10 June 2026).

    Wang, J., Li, M., Zhang, Z., Duan, Y., Zhang, Z., Liu, H. et al. (2025) ‘Association between mental disorders and trigeminal neuralgia: a cohort study and Mendelian randomization analysis’, The Journal of Headache and Pain, 26, 74. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC11992777/ (Accessed: 10 June 2026).

    Wu, T.H., Hu, L.Y., Lu, T. et al. (2019) ‘Effects of Depression and Anxiety on Microvascular Decompression Outcome for Trigeminal Neuralgia Patients’, World Neurosurgery. Available at: https://www.sciencedirect.com/science/article/abs/pii/S1878875019311891 (Accessed: 10 June 2026).

  • Allostatic Load and the “Pace of Life Syndrome” in Borderline Personality Disorder: What the Evidence Tells Us

    Allostatic Load and the “Pace of Life Syndrome” in Borderline Personality Disorder: What the Evidence Tells Us

    Borderline Personality Disorder (BPD) is widely understood as a condition of profound emotional and psychological instability — a disorder that disrupts relationships, identity, and the capacity for self-regulation. What is far less widely appreciated, however, is the degree to which BPD is also a disorder of the body. Beneath the clinical surface of emotional dysregulation lies a measurable, multi-system biological crisis rooted in chronic stress exposure, early adversity, and accelerated physiological deterioration. Two theoretical frameworks are increasingly central to understanding this phenomenon: the concept of Allostatic Load (AL) and the evolutionary model known as the Pace-of-Life Syndrome (PoLS). Together, these frameworks offer a powerful lens through which to understand why individuals with BPD experience dramatically shortened lifespans and elevated rates of physical illness — and why addressing these realities must become a clinical and policy priority in the United Kingdom.

    Advertisements

    Understanding Allostatic Load

    The concept of allostatic load was originally developed by the American neuroscientist Bruce McEwen in 1998 to quantify the cumulative physiological “wear and tear” that chronic stress inflicts upon the body’s regulatory systems over time. Where acute stress activates adaptive physiological responses — the well-documented fight-or-flight mechanism — chronic stress, when sustained and unresolved, produces a progressive overactivation of those same systems, eventually leading to their dysregulation and breakdown (O’Connor et al., 2020 ). Allostatic load is an objective, composite measure of this accumulated physiological burden, estimated through biomarkers spanning the neuroendocrine, cardiovascular, metabolic, and inflammatory systems — including cortisol, blood pressure, body mass index, C-reactive protein (CRP), and glycated haemoglobin (Jakubowski et al., 2023).

    A large 2025 study drawing on data from 205,504 adults in the UK Biobank — one of the world’s most comprehensive biological research databases — found that elevated allostatic load was associated with a graded increase in cardiovascular disease risk, with neutrophil-driven inflammation emerging as a key biological mediator between chronic stress and cardiac damage (The Mighty, 2025). A further UK Biobank study, using data from the Edinburgh-based Lothian Birth Cohort, demonstrated a significant positive association between allostatic load and accelerated brain ageing — specifically in white matter microstructure — suggesting that chronic stress does not merely age the body, but measurably alters the biological trajectory of the brain itself (Vail et al., 2024).

    The Pace-of-Life Syndrome: BPD as an Evolutionary Adaptation Gone Wrong

    The Pace-of-Life Syndrome is a theoretical model drawn from evolutionary life history theory — a framework that describes how organisms allocate biological resources between survival, growth, and reproduction in response to environmental conditions. In environments characterised by high adversity, unpredictability, and early threat exposure, organisms — including humans — adopt a “fast” life history strategy: accelerating development, reproduction, and metabolic expenditure in response to the implicit biological signal that the future is uncertain and time is short (Otto, Kokkelink and Brüne, 2021). This fast PoLS profile is characterised by heightened impulsivity, earlier reproductive investment, elevated aggression, chronic stress reactivity, and — crucially — a willingness to prioritise short-term gain at the expense of long-term biological maintenance and repair.

    The proposition that BPD reflects a pathological expression of a fast Pace-of-Life Syndrome has been empirically tested and supported. In a controlled study recruiting 95 women, 44 of whom carried a BPD diagnosis, researchers found that BPD patients demonstrated significantly higher scores on fast PoLS indicators: greater childhood adversity, more severe chronic stress, heightened aggressiveness, and — critically — elevated allostatic load compared to controls. The causal pathway revealed was striking: childhood trauma predicted PoLS, which in turn directly predicted allostatic load, providing the first direct empirical evidence of a pathway linking early adversity to somatic deterioration in BPD through the mediating mechanism of life history strategy (Otto, Kokkelink and Brüne, 2021). Put simply, the same psychological adaptations that helped individuals survive early environments of danger and instability are, in adulthood, slowly destroying the body from within.

    💎 The HPA Axis, Childhood Trauma, and BPD

    🧁 Subscribe or Buy a Cupcake for Betshy to get access to the full article.

    It’s worth reading…

    Subscribe

    References

    Biological Psychiatry (2024) ‘Association of Allostatic Load With Depression, Anxiety, and Suicide: A Prospective Cohort Study’, Biological Psychiatry. Available at: https://www.biologicalpsychiatryjournal.com/article/S0006-3223(24)01655-X/abstract (Accessed: 5 June 2026).

    Borderline Support UK (2024) NHS and NICE Guidelines for Treatment of BPD. Available at: https://borderlinesupport.org.uk/lesson/nhs-and-nice-guidelines-for-treatment-of-bpd/ (Accessed: 5 June 2026).

    Bozzatello, P., Marin, G., Gabriele, G., Brasso, C., Rocca, P. and Bellino, S. (2024) ‘Metabolic Dysfunctions, Dysregulation of the Autonomic Nervous System, and Echocardiographic Parameters in Borderline Personality Disorder: A Narrative Review’, International Journal of Molecular Sciences, 25(22), 12286. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11594816/ (Accessed: 5 June 2026).

    British Journal of Medical Practitioners (n.d.) ‘A review of NICE guidelines on the management of Borderline Personality Disorder’, British Journal of Medical Practitioners. Available at: https://www.bjmp.org/content/review-nice-guidelines-management-borderline-personality-disorder (Accessed: 5 June 2026).

    Bunea, I.M., Szentágotai-Tătar, A. and Miu, A.C. (2022) ‘Childhood Trauma, the HPA Axis and Psychiatric Illnesses: A Targeted Literature Synthesis’, Frontiers in Psychiatry, 13, 748372. Available at: https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2022.748372/full (Accessed: 5 June 2026).

    Jakubowski, D., Peterson, C.E., Sun, J., Hoskins, K., Rauscher, G.H. and Argos, M. (2023) ‘Association between adverse childhood experiences and later-life allostatic load in UK Biobank female participants’, Women’s Health, 19. Available at: https://journals.sagepub.com/doi/10.1177/17455057231184325 (Accessed: 5 June 2026).

    Leichsenring, F., Fonagy, P., Heim, N., Kernberg, O.F., Leweke, F., Luyten, P., Salzer, S., Spitzer, C. and Steinert, C. (2024) ‘Borderline personality disorder: a comprehensive review of diagnosis and clinical presentation, etiology, treatment, and current controversies’, World Psychiatry, 23(1), pp. 4–25. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC10786009/ (Accessed: 5 June 2026).

    National Institute for Health and Care Excellence (2009) Borderline Personality Disorder: Recognition and Management (CG78). Available at: https://www.nice.org.uk/guidance/cg78 (Accessed: 5 June 2026).

    O’Connor, R.C., Wetherall, K., Cleare, S., Eschle-Taylor, S., Bhatt, M. and Kirtley, O.J. (2020) ‘Effects of childhood trauma, daily stress, and emotions on cortisol levels in people at elevated suicide risk’, Journal of Abnormal Psychology. White Rose Universities Consortium. Available at: https://eprints.whiterose.ac.uk/id/eprint/150681/3/OConnor%20et%20al_J_Abn_Psyc_ACCEPTED.pdf (Accessed: 5 June 2026).

    Otto, B., Kokkelink, L. and Brüne, M. (2021) ‘Borderline Personality Disorder in a “Life History Theory” Perspective: Evidence for a Fast “Pace-of-Life-Syndrome”‘, Frontiers in Psychology, 12, 715153. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350476/ (Accessed: 5 June 2026).

    The Mighty (2025) What Is Allostatic Load? The Science of Trauma on the Body. Available at: https://themighty.com/topic/post-traumatic-stress-disorder-ptsd/what-is-allostatic-load/ (Accessed: 5 June 2026).

    Vail, E. et al. (2024) ‘Association between allostatic load and accelerated white matter brain aging: findings from the UK Biobank’, medRxiv [Preprint]. Available at: https://www.medrxiv.org/content/10.1101/2024.01.26.24301793.full.pdf (Accessed: 5 June 2026).

  • Borderline Personality Disorder and Life Expectancy: Examining the Evidence Behind the Premature Death Claim

    Borderline Personality Disorder and Life Expectancy: Examining the Evidence Behind the Premature Death Claim

    Among the many sobering realities associated with Borderline Personality Disorder (BPD), perhaps none demands more urgent clinical and public attention than its profound impact on life expectancy. A claim now circulating widely in mental health discourse — that BPD can shorten a person’s life by up to 20 years — is not a figure born of speculation. It is grounded in a growing body of peer-reviewed longitudinal research that collectively paints a troubling picture of premature mortality risk in this population. Yet the “20-year” headline, while broadly accurate, is more nuanced than it first appears. The evidence points to a range of outcomes shaped by comorbidities, socioeconomic factors, access to care, and biological mechanisms that science is only beginning to fully understand. This article examines that evidence in detail, interrogating where the figure comes from, what drives it, and what can be done to narrow the gap.

    Advertisements

    Where Does the “20-Year” Figure Come From?

    The most frequently cited estimate is that individuals with BPD face a reduction in life expectancy of approximately 10 to 20 years compared to the general population (Euler et al., 2025 ). Other studies extend this further: longitudinal research has estimated that people with personality disturbances more broadly — with BPD representing the most clinically severe — face a reduction in life expectancy of between 13 and 27.5 years, owing to a substantially elevated all-cause mortality risk, particularly among younger individuals (Rincón Ferrari et al., 2024). This wide range reflects genuine variation in study design, sample characteristics, and follow-up periods — but across all estimates, the direction of the evidence is unambiguous: BPD is associated with markedly shortened lifespans.

    The most methodologically rigorous evidence underpinning this claim comes from the McLean Study of Adult Development (MSAD), a prospective 24-year longitudinal investigation conducted at Harvard-affiliated McLean Hospital. Following 290 patients with BPD against 72 comparison patients with other personality disorders, the study found that after 24 years, 5.9% of BPD patients had died by suicide, compared with 1.4% of comparison patients. More strikingly, a further 14.0% of BPD patients died from other causes — nearly three times the 5.5% rate observed in the comparison group (Temes et al., 2019). The principal investigators concluded that premature mortality in BPD is comparable in scale to that observed in other serious mental illnesses, including schizophrenia and treatment-resistant mood disorders (Medscape, 2019).

    Suicide: Real, Significant, But Not the Whole Story

    Any honest discussion of BPD mortality must begin with suicide, which remains the most clinically visible and statistically documented contributor to early death in this population. Between 46% and 92% of individuals with BPD will attempt suicide at least once during their lifetime, and between 3% and 10% will die by suicide — a rate dramatically higher than both the general population and many other psychiatric diagnoses (Euler et al., 2025 ). Factors shown to predict completed suicide in BPD include prior suicidal behaviour, a greater number of psychiatric hospitalisations, and the presence of significant psychiatric comorbidities (Medscape, 2019).

    However, a critical finding from the McLean MSAD and subsequent studies is that suicide alone does not account for the full extent of the mortality gap. In the McLean cohort, non-suicidal causes of death — including cardiovascular disease (n=11), substance-related complications (n=5), cancer (n=4), and accidents (n=4) — collectively exceeded suicide as a cause of premature death in BPD patients who did not achieve recovery (Temes et al., 2019). This finding has significant implications for how clinicians approach the condition: a singular focus on suicide prevention, while essential, is insufficient to address the full spectrum of life-threatening risk.

    Physical Health: The Silent Driver of Early Death

    The physical health burden carried by individuals with BPD is substantially underappreciated in mainstream clinical and public discourse. Research confirms that BPD independently elevates the risk of cardiovascular disease, hypertension, obesity, diabetes, arteriosclerosis, arthritis, gastrointestinal disorders, hepatic disease, and sexually transmitted infections (Rincón Ferrari et al., 2024). A dedicated echocardiographic study found that female BPD patients showed significantly increased epicardial adipose tissue — an established sensitive marker for cardiovascular disease risk — alongside reduced indices of cardiac function, compared to matched controls, suggesting that structural cardiac changes may begin early in the illness course (Euler et al., 2025 ).

    The theoretical framework known as the “Pace-of-Life Syndrome” offers one explanatory model for why physical deterioration occurs so pervasively in BPD. Rooted in evolutionary biology, this framework argues that the chronic stress, early adversity, and emotional hyperreactivity characteristic of BPD produce a state of elevated allostatic load — the cumulative physiological wear caused by chronic psychological stress — that accelerates biological ageing and systemic organ damage over time (Otto, Kokkelink and Brüne, 2021). In clinical settings, BPD is associated with an 8.3-fold higher all-cause mortality compared to the general population — a figure that situates it firmly in the category of serious public health concern (Otto, Kokkelink and Brüne, 2021).

    Comorbidities and the Compounding Effect

    BPD rarely exists in isolation, and the life expectancy implications of its comorbidities are considerable. The vast majority of individuals diagnosed with BPD also experience at least one mood disorder — most commonly major depressive disorder or bipolar disorder — alongside elevated rates of anxiety disorders, post-traumatic stress disorder, eating disorders, and attention-deficit hyperactivity disorder (MH Stats, 2026). Substance Use Disorders (SUD) are present in approximately 60% of clinical BPD samples and constitute one of the strongest independent predictors of non-suicidal premature death, contributing directly to cardiovascular complications, accidental overdose, and immune system compromise over time (Grouport Therapy, 2023).

    The temporal dimension of BPD across the lifespan adds further complexity. Research shows that while core BPD symptoms — including affective dysregulation, impulsivity, and suicidality — tend to diminish in intensity with age, maladaptive interpersonal functioning and functional impairment often persist and evolve in presentation, meaning that risk does not simply disappear as patients grow older (Zanarini et al., 2019). The cumulative toll of decades of emotional dysregulation, poor health behaviours, medication side effects, and systemic neglect by healthcare services produces a form of accelerated biological ageing that is difficult to reverse in later life.

    Stigma, Systemic Barriers, and the Access Gap

    A crucial but frequently overlooked contributor to the mortality gap in BPD is the pervasive stigma attached to the diagnosis — both among the general public and within healthcare systems themselves. Individuals with BPD consistently report experiencing negative, dismissive, or even punitive treatment from health practitioners, which generates significant reluctance to seek medical care and sustain treatment engagement (Euler et al., 2025 ). This stigma compounds the already considerable barriers to accessing consistent, high-quality physical and mental healthcare — particularly in under-resourced healthcare systems where BPD-specific expertise is limited (MH Stats, 2026). A significant treatment delay exists between the onset of BPD symptoms, which often emerge in adolescence, and the point at which an individual first receives an accurate diagnosis and appropriate care (MH Stats, 2026).

    Closing the Gap: What the Evidence Recommends

    The mortality gap associated with BPD is not immutable. Effective interventions exist, and early deployment of these interventions measurably improves both quality of life and long-term survival outcomes. Dialectical Behaviour Therapy (DBT), the gold-standard treatment specifically developed for BPD, has demonstrated robust efficacy in reducing self-harm, suicidality, emotional dysregulation, and the impulsive health-damaging behaviours that drive early physical deterioration (Biology Insights, 2025). Researchers from McLean Hospital have called for treatment models that go beyond symptomatic management to actively address poor health behaviours, substance use, social isolation, and physical health monitoring — paralleling rehabilitation approaches used in schizophrenia care (Medscape, 2019).

    Integrated care models that coordinate psychiatric treatment with primary and physical healthcare are strongly supported by current evidence (Biology Insights, 2025). The scientometric literature on BPD spanning twenty years of published research has also called for greater global investment in BPD-specific clinical trials, standardised treatment protocols, and anti-stigma initiatives at both clinical and policy levels (Liu et al., 2024).

    Conclusion

    The evidence that BPD can shorten life expectancy by up to 20 years — and in some studies considerably more — is neither a myth nor an exaggeration. It is a research-grounded reality that emerges consistently across longitudinal studies, biological investigations, and clinical reviews. Suicide, while a defining risk, is only one contributor within a broader constellation of physical illness, psychiatric comorbidity, substance use, systemic neglect, and chronic biological stress that collectively erodes the lifespans of those living with this diagnosis. What the science now makes clear is that BPD must be treated not merely as a mental health condition, but as a serious, life-limiting illness warranting the same level of coordinated, sustained, and adequately funded clinical attention that other life-shortening disorders receive.

    If you or someone you know is living with BPD or experiencing thoughts of self-harm or suicide, please reach out for support. In the UK, contact NHS 111 (option 2), or the Samaritans on 116 123 (free, 24/7). In the US, call or text 988 (Suicide and Crisis Lifeline). Wherever you are, seek support if you don’t already have it.

    References

    Biology Insights (2025) What Is the Mortality Rate for BPD? Available at: https://biologyinsights.com/what-is-the-mortality-rate-for-bpd/ (Accessed: 1 June 2026).

    Euler, S. et al. (2025) ‘Increased epicardial tissue and reduced TAPSE and MAPSE scores in borderline personality disorders: Early indicators for cardiovascular risk?’, PMC. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12175066/ (Accessed: 1 June 2026).

    Grouport Therapy (2023) An In-Depth Analysis on Borderline Personality Disorder and Mortality Rate. Available at: https://www.grouporttherapy.com/blog/bpd-mortality-rate (Accessed: 1 June 2026).

    Liu, Y. et al. (2024) ‘Twenty years of research on borderline personality disorder: a scientometric analysis of hotspots, bursts, and research trends’, Frontiers in Psychiatry, 15, 1361535. Available at: https://pubmed.ncbi.nlm.nih.gov/38495902/ (Accessed: 1 June 2026).

    Medscape (2019) ‘Early Death in BPD Patients Not Just Because of Suicide’, Medscape, 24 May. Available at: https://www.medscape.com/viewarticle/913222 (Accessed: 1 June 2026).

    MH Stats (2026) Borderline Personality Disorder Statistics 2026. Available at: https://mhstats.org/conditions/bpd/ (Accessed: 1 June 2026).

    Otto, B., Kokkelink, L. and Brüne, M. (2021) ‘Borderline Personality Disorder in a “Life History Theory” Perspective: Evidence for a Fast “Pace-of-Life-Syndrome”‘, Frontiers in Psychology, 12, 715153. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350476/ (Accessed: 1 June 2026).

    Rincón Ferrari, M.D. et al. (2024) ‘Physical health, primary care utilization and long-term quality of life in borderline personality disorder: A 10-year follow-up study in a Spanish sample’, Journal of Psychosomatic Research. Available at: https://www.sciencedirect.com/science/article/abs/pii/S0022399924000357 (Accessed: 1 June 2026).

    Temes, C.M. et al. (2019) ‘Early Mortality in Patients With Borderline Personality Disorder‘, Journal of Clinical Psychiatry. Reported in: Psychiatry Advisor. Available at: https://www.psychiatryadvisor.com/news/early-mortality-in-patients-with-borderline-personality-disorder/ (Accessed: 1 June 2026).

    Zanarini, M.C. et al. (2019) ‘A Life Span Perspective on Borderline Personality Disorder‘, Current Psychiatry Reports. Available at: https://link.springer.com/article/10.1007/s11920-019-1040-1 (Accessed: 1 June 2026).

  • 7 Things Every Person Diagnosed with Schizophrenia Should Know About the Mental Health Act in the UK

    7 Things Every Person Diagnosed with Schizophrenia Should Know About the Mental Health Act in the UK

    For individuals living with schizophrenia in the United Kingdom, understanding the legal framework that governs mental health care is not merely an academic exercise — it is a matter of fundamental rights. The Mental Health Act 1983, as significantly amended by the Mental Health Act 2007 and now further reformed by the Mental Health Act 2025, is the primary piece of legislation that determines when and how a person with a mental disorder can be detained in hospital, treated, and supported in the community (Mental Health Act 2025 ). Schizophrenia is explicitly recognised within this legal framework as a condition that falls under the Act’s definition of mental disorder (South West Yorkshire Partnership NHS Foundation Trust, 2024). Whether you are a patient, a carer, or a family member, this knowledge can make a profound difference at a critical time.

    Advertisements

    It is important to note that the Mental Health Act applies to England and Wales. Separate statutory provisions govern Scotland and Northern Ireland (House of Commons Library, 2024). This article outlines the key things every person with schizophrenia should know about their rights under this legislation.

    1. The Act Applies Directly to Schizophrenia

    The Mental Health Act defines mental disorder as “any disorder or disability of the mind.” This definition is deliberately broad and is widely understood by psychiatrists to include schizophrenia, alongside major depression, bipolar disorder, and other serious mental illnesses (South West Yorkshire Partnership NHS Foundation Trust, 2024). However, having a diagnosis of schizophrenia alone does not automatically mean a person is subject to the Act’s provisions. A person must also pose a risk to themselves or others, and less restrictive alternatives must have already been considered and found insufficient (Northamptonshire Healthcare NHS Foundation Trust, n.d.).

    2. Understanding “Sectioning” — What It Really Means

    Being “sectioned” means being detained in hospital under one of the sections of the Mental Health Act, even if you do not consent. This is done to keep you safe and to ensure you receive necessary treatment (Mind, 2025). The most frequently used sections are Section 2 and Section 3. Section 2 is an assessment order lasting up to 28 days and cannot be renewed; if further hospitalisation is needed, clinicians must move to a Section 3 order. Under the Mental Health Act 2025, the initial Section 3 detention period has been reduced from six months to three months, with more frequent mandatory reviews to ensure detention is only used when necessary (Community Care, 2026). Section 4 is an emergency provision lasting 72 hours, used only when waiting for a second doctor would cause a dangerous delay (Mind, 2025).

    3. You Have the Right to Appeal Your Detention

    One of the most critical rights every detained person with schizophrenia should exercise is the right to appeal. Under Section 2, a patient can apply to the First-Tier Tribunal (Mental Health) within the first 21 days of detention. Under Section 3, this window has been extended under the 2025 reforms, and automatic referrals to the tribunal now occur after three months and then every 12 months — ensuring far more frequent independent reviews than previously required (Royal College of Psychiatrists, 2026). Detained persons have the statutory right to be represented at tribunal hearings by a solicitor (Rethink Mental Illness, 2026). Patients can also appeal directly to the hospital managers, who have the authority to discharge them from detention.

    4. You Are Entitled to an Independent Mental Health Advocate (IMHA)

    Every patient detained under the Mental Health Act has a legal right to access an Independent Mental Health Advocate (IMHA). IMHAs are specially trained advocates who can help patients understand their rights, attend meetings on their behalf, and ensure their voice is heard in care planning decisions (Rethink Mental Illness, 2026). A significant improvement introduced by the Mental Health Act 2025 is the extension of this right to informal (voluntary) patients in England — a right that was previously only available to those formally detained. The Act also introduces an “opt-out” system, meaning hospitals must proactively notify advocacy services of qualifying patients, rather than leaving patients to seek help themselves (Local Government Association, 2025). If you or a loved one with schizophrenia is admitted to hospital, requesting an IMHA should be a priority.

    5. Your Right to Free Aftercare Under Section 117

    Section 117 of the Mental Health Act is one of the most practically important — and most underutilised — legal protections available to people with schizophrenia. If you have been detained under Section 3 (or several other qualifying sections), the NHS and your local authority have a legal duty to provide free aftercare services upon discharge (South London and Maudsley NHS Foundation Trust, n.d.). These aftercare services may include community mental health support, housing assistance, medication management, and social care. These services cannot be charged to the patient. A care plan must be written in advance of discharge, identifying the support to be provided and who is responsible for each element (South London and Maudsley NHS Foundation Trust, n.d.). The Mental Health Act 2025 has further strengthened Section 117 by clarifying which local authority holds responsibility when a patient is placed out of their home area, and by empowering the Mental Health Tribunal to recommend that aftercare be put in place — and to reconvene if those recommendations are ignored (Community Care, 2026).

    6. The Nominated Person — Replacing the “Nearest Relative”

    Previously, the law designated a “nearest relative” for each detained patient — a role determined by a fixed legal hierarchy regardless of the patient’s actual wishes or relationships. The Mental Health Act 2025 replaces this with the concept of a “nominated person” — someone the patient themselves chooses to fulfil this important role (House of Commons Library, 2024). For people with schizophrenia, who may have complex or difficult family dynamics, this change is enormously significant. The nominated person has statutory rights, including the ability to request a patient’s discharge, object to detention, and be consulted on care plans. Choosing a trusted nominated person in advance — ideally in conjunction with an Advance Choice Document — is one of the most empowering steps a person with schizophrenia can take.

    7. The Mental Health Act 2025 — What Has Changed and Why It Matters

    The Mental Health Act 2025 received Royal Assent on 18 December 2025, representing the most significant reform of UK mental health law in over four decades (Royal College of Psychiatrists, 2026). The reforms were driven by several longstanding concerns: rising rates of detention, significant racial inequalities in the use of compulsory powers, and the inappropriate detention of autistic people and those with learning disabilities (Care Quality Commission, 2025). For people with schizophrenia, the core ambition of the new Act — to ensure that detention is only used when, and for as long as, strictly necessary — is directly relevant. The Care Quality Commission, which regulates the Act’s use, has emphasised its commitment to revising the Code of Practice in 2026 to embed principles of choice, autonomy, least restriction, and therapeutic benefit at the heart of clinical decision-making (Care Quality Commission, 2025). Crucially, the Act is expected to be implemented in stages over approximately ten years, meaning some changes will not come into effect immediately.

    Conclusion

    Navigating the mental health system can be deeply challenging for anyone living with schizophrenia, but being informed about your legal rights is an essential first step toward self-advocacy and empowered care. From understanding the difference between Section 2 and Section 3, to accessing an IMHA, claiming your Section 117 aftercare entitlements, and choosing a nominated person, the law provides meaningful protections that every patient, carer, and family member should know. The Mental Health Act 2025 marks a significant step forward in placing the patient’s voice at the centre of care — but realising that promise will require both systemic investment and individual awareness. If you need immediate guidance, charities such as Mind and Rethink Mental Illness provide free, accessible information and support.

    References

    Care Quality Commission (2025) The Mental Health Act 1983 (amended 2025). Available at: https://www.cqc.org.uk/publications/monitoring-mental-health-act/2024-2025/mha (Accessed: 18 May 2026).

    Community Care (2024) ‘How the government plans to reform the Mental Health Act 1983’, Community Care, 7 November. Available at: https://www.communitycare.co.uk/2024/11/07/how-the-government-plans-to-reform-the-mental-health-act-1983/ (Accessed: 18 May 2026).

    Community Care (2026) ‘The Mental Health Act 2025 summarised’, Community Care, 11 March. Available at: https://www.communitycare.co.uk/content/news/the-mental-health-act-2025-summarised (Accessed: 18 May 2026).

    House of Commons Library (2024) Reforming the Mental Health Act: Independent Review to Draft Bill. Available at: https://commonslibrary.parliament.uk/research-briefings/cbp-9132/ (Accessed: 18 May 2026).

    Local Government Association (2025) Get in on the Act: Mental Health Act 2025. Available at: https://www.local.gov.uk/publications/get-act-mental-health-act-2025 (Accessed: 18 May 2026).

    Mental Health Act 2025 (c. 33). Available at: https://www.legislation.gov.uk/ukpga/2025/33/enacted (Accessed: 18 May 2026).

    Mind (2025) Being Sectioned Under the Mental Health Act. Available at: https://www.mind.org.uk/information-support/legal-rights/sectioning/about-sectioning/ (Accessed: 18 May 2026).

    Northamptonshire Healthcare NHS Foundation Trust (n.d.) Mental Health Act. Available at: https://www.nhft.nhs.uk/mental-health-act (Accessed: 18 May 2026).

    Rethink Mental Illness (2026) What is the Mental Health Act? Available at: https://www.rethink.org/advice-and-information/rights-laws-and-criminal-justice/mental-health-laws/mental-health-act/ (Accessed: 18 May 2026).

    Royal College of Psychiatrists (2026) ‘Mental Health Bill (England and Wales) receives Royal Assent’, 14 January. Available at: https://www.rcpsych.ac.uk/news-and-features/latest-news/detail/2026/01/14/mental-health-bill-(england-and-wales)-receives-royal-assent (Accessed: 18 May 2026).

    Royal College of Psychiatrists (n.d.) Reforming the Mental Health Act. Available at: https://www.rcpsych.ac.uk/improving-care/campaigning-for-better-mental-health-policy/reforming-the-mental-health-act (Accessed: 18 May 2026).

    South London and Maudsley NHS Foundation Trust (n.d.) Section 117 Aftercare. Available at: https://slam.nhs.uk/section-117-aftercare (Accessed: 18 May 2026).

    South West Yorkshire Partnership NHS Foundation Trust (2024) Mental Health Act. Available at: https://www.southwestyorkshire.nhs.uk/service-users-and-carers/your-rights/mental-health-act/ (Accessed: 18 May 2026).

  • Ontological Autonomy: How to Reclaim Your Sense of Self in a Chaotic World

    Ontological Autonomy: How to Reclaim Your Sense of Self in a Chaotic World

    In a world that constantly demands we perform, conform, and outsource our identity to algorithms, trends, and external validation, the concept of ontological autonomy has never been more relevant. It represents the hard-won ability to exist as a coherent, self-authored being — not defined by others’ expectations, trauma, or societal scripts, but rooted in one’s own authentic sense of being.

    Advertisements

    Ontological autonomy builds directly on the work of thinkers who explored ontological security and insecurity. While ontological insecurity (Laing, 1960) describes a fragile sense of self that feels constantly threatened with dissolution or engulfment, ontological autonomy is its empowered counterpart: the capacity to maintain a stable, continuous sense of “I am” even when faced with chaos , rejection, or existential pressure. This autonomy enables individuals to navigate life’s uncertainties with resilience and self-assuredness, fostering a deeply rooted understanding of one’s identity that remains intact despite external challenges.

    Furthermore, ontological autonomy not only encourages personal growth but also promotes healthier relationships, as it allows individuals to engage authentically with others while maintaining their own sense of self amidst the fluctuating dynamics of interpersonal connections and societal expectations. In this way, the concept of ontological autonomy serves as a vital psychological resource, equipping individuals with the strength to confront adversities and embrace their true selves without fear of losing their essence.

    Philosopher Jean-Paul Sartre laid important groundwork through his concept of bad faith — the denial of one’s freedom by hiding behind roles, excuses, or external definitions. This notion underscores the psychological struggles many individuals face in accepting the full weight of their choices and the freedom that accompanies them. True ontological autonomy, in Sartrean terms, requires radical acceptance of freedom and responsibility for one’s existence. Such acceptance is not merely an intellectual exercise; it demands a courageous confrontation with the self and an acknowledgment of the inherent anxieties that accompany genuine freedom.

    To live authentically is to refuse the temptation to let others (or circumstances) define who we are, actively crafting our own identities and destinies instead. This journey towards authenticity is fraught with challenges, as societal expectations and personal fears continuously threaten to pull us back into patterns of bad faith, where we might find temporary comfort but ultimately lose the essence of our true selves (Sartre, 1943) .

    Sociologist Anthony Giddens expanded this idea in late modernity, delving deeply into the complexities of contemporary identity and social structures. He argued that ontological security, a crucial aspect of human experience, comes from maintaining a reliable self-narrative and trusting in the continuity of social structures that provide stability in daily life. This stability is essential for individuals to navigate an increasingly complex world. In this sense, individuals must actively reflect on their beliefs, experiences, and social contexts, allowing them to adapt their identities as needed in response to changing circumstances. Such adaptability becomes even more vital in an era of rapid social transformation and uncertainty, where traditional norms and values may no longer hold the same weight as they once did, necessitating a more dynamic approach to identity formation and personal meaning (Giddens, 1991).

    Ontological autonomy, then, is the ability to sustain that narrative even when those structures crumble, requiring individuals to engage in reflexive self-understanding and deliberate identity construction.

    In clinical psychology, ontological autonomy is closely linked to Self-Determination Theory (Deci & Ryan, 2000), which emphasises the importance of individuals having the freedom to make choices and govern their own lives. The theory identifies autonomy as one of three basic psychological needs (alongside competence and relatedness), highlighting that fulfilling these needs is crucial for psychological well-being and optimal functioning. When this need is thwarted — often through controlling relationships, oppressive environments, or internalised shame — people experience alienation from their true desires and values, leading to feelings of frustration and demotivation. This disconnection can manifest in various ways, including anxiety, depression, and a sense of helplessness.

    Cultivating ontological autonomy means reclaiming authorship over one’s life choices and inner experience, fostering a deeper sense of self and stronger personal agency. By understanding and addressing the factors that impede autonomy, individuals can work towards a more authentic existence, aligning their actions with their true selves and ultimately enhancing their overall quality of life (Deci & Ryan, 2000). For trauma survivors, ontological autonomy is frequently compromised. Complex trauma can shatter the sense of a continuous, worthy self, leaving individuals feeling fragmented or defined by their wounds.

    Healing involves slowly rebuilding an internal locus of control — learning that one’s worth and reality are not dictated by past perpetrators or current circumstances. In my own journey and forensic work, I have seen how reclaiming ontological autonomy is often the turning point from survival to genuine thriving. Practically, developing ontological autonomy involves several key practices:

    • Reflexive self-awareness — regularly examining the stories we tell ourselves about who we are.
    • Boundary work — learning to say “no” without guilt and protecting personal values.
    • Value clarification — identifying what truly matters independent of external approval.
    • Tolerating existential anxiety — sitting with uncertainty rather than rushing to external validation.

    In today’s hyper-connected world, ontological autonomy is under constant threat. Social media encourages performative identities, while political and economic systems often reduce people to data points or consumers. Reclaiming it is therefore an act of quiet rebellion — a declaration that your inner reality matters.

    The journey is rarely linear. There will be days when old fears of abandonment or worthlessness pull you back into dependency. But each time you choose authenticity over approval, you strengthen the muscle of ontological autonomy. Over time, the self becomes less fragile and more resilient — not because the world becomes safer, but because you become more rooted in your own being.

    In conclusion, ontological autonomy is not selfish individualism. It is the foundation of genuine connection, ethical living, and psychological freedom. By understanding and cultivating it, we move from being shaped by the world to becoming conscious co-creators of our reality. In a time of fragmentation and noise, this may be one of the most radical and healing things we can do — both for ourselves and for the collective.

    References

    Deci, E. L. and Ryan, R. M. (2000) ‘The “what” and “why” of goal pursuits: Human needs and the self-determination of behavior’, Psychological Inquiry, 11(4), pp. 227–268. Available at: https://psycnet.apa.org/record/2000-13324-001 (Accessed: 26 March 2026).

    Giddens, A. (1991) Modernity and Self-Identity: Self and Society in the Late Modern Age. Stanford: Stanford University Press. Available at: https://www.politybooks.com/bookdetail/?isbn=9780745609324 (Accessed: 26 March 2026).

    Laing, R. D. (1960) The Divided Self: An Existential Study in Sanity and Madness. London: Penguin. Available at: https://www.penguinrandomhouse.com/books/264434/the-divided-self-by-r-d-laing/ (Accessed: 26 March 2026).

    Sartre, J-P. (1943) Being and Nothingness. London: Routledge. Available at: https://www.routledge.com/Being-and-Nothingness/Sartre/p/book/9780415274739 (Accessed: 26 March 2026).

  • The Psychological Trauma of Being Arrested: Understanding Its Impact

    The Psychological Trauma of Being Arrested: Understanding Its Impact

    As someone who has worked with trauma survivors and lived through my own mental health challenges, I know how deeply an arrest can wound a person — even when no conviction follows. Being arrested is not just a legal event; it is often a profound psychological trauma that can leave lasting scars on the mind, body, and sense of self.

    Advertisements

    The moment of arrest triggers an immediate and intense activation of the body’s stress response. Handcuffs, physical restraint, public exposure, and the sudden loss of freedom flood the nervous system with cortisol and adrenaline. Many people describe it as feeling like “time stops” or entering a dissociative state. This acute stress can be as traumatic as a physical assault, especially when force is used or the arrest feels unjustified (Geller et al., 2014) .

    For many, the trauma begins with the loss of autonomy. Being placed in handcuffs, searched, and transported in a police vehicle can trigger deep feelings of powerlessness and humiliation. Research shows that individuals who experience arrest often report symptoms similar to those seen in post-traumatic stress disorder (PTSD), including intrusive memories, hypervigilance, nightmares, and avoidance behaviours (Sugie and Turney, 2017). The public nature of many arrests adds a layer of social shame that can persist for years.

    The psychological impact extends far beyond the event itself. Even a short period in custody can shatter a person’s sense of safety and trust in the world. For those with pre-existing trauma, an arrest can re-activate old wounds, leading to complex PTSD symptoms. Many report lasting changes in how they view authority figures, institutions, and even their own worth. The stigma of having been arrested — whether charges are dropped or not — can damage relationships, employment prospects, and self-identity (Baćak and Nowotny, 2020).

    Physiologically, the body remembers. Chronic hyperarousal, sleep disturbances, and heightened startle responses are common. Some individuals develop somatic symptoms such as tension headaches, gastrointestinal issues, or chronic pain as the body continues to hold and convert the unprocessed trauma. Studies on recently arrested individuals show elevated rates of depression, anxiety, and substance use as maladaptive coping mechanisms.

    The trauma is often compounded by systemic factors. Marginalised communities — particularly people of colour, those from low-income backgrounds, and individuals with mental health conditions — experience higher rates of arrest and report more traumatic encounters with law enforcement. This creates a cycle where systemic injustice and personal trauma reinforce each other (Sewell et al., 2021).

    Recovery from arrest-related trauma requires gentle, trauma-informed support. Approaches such as EMDR (Eye Movement Desensitisation and Reprocessing), somatic experiencing, and trauma-focused cognitive behavioural therapy can be highly effective. Equally important is social validation — being believed and supported rather than judged or stigmatised.

    In my forensic journey and personal reflections, I have seen how an arrest can fracture a person’s sense of safety in the world. Healing begins when we acknowledge the depth of that wound without shame. If you or someone you love has experienced the trauma of arrest, know that your reactions are normal responses to an abnormal event. You are not broken — you are responding to something that was profoundly violating.

    The trauma of being arrested reminds us how fragile our sense of freedom and dignity can be. By bringing awareness and compassion to this experience, we take an important step toward healing both individuals and the systems that sometimes cause unnecessary harm.

    References

    Baćak, V. and Nowotny, K. M. (2020) ‘Criminal justice contact and health: Does race matter?’, Sociology of Race and Ethnicity, 6(3), pp. 337–352. Available at: https://journals.sagepub.com/doi/full/10.1177/0038040720914863 (Accessed: 26 March 2026).

    Geller, A. et al. (2014) ‘Aggressive policing and the mental health of young urban men’, American Journal of Public Health, 104(12), pp. 2321–2327. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4103812/ (Accessed: 26 March 2026).

    Sewell, A. A. et al. (2021) ‘Police violence and public health: A review of the literature’, Annual Review of Sociology, 47, pp. 527–548. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8118190/ (Accessed: 26 March 2026).

    Sugie, N. F. and Turney, K. (2017) ‘Beyond incarceration: Criminal justice contact and mental health’, American Sociological Review, 82(4), pp. 719–743. Available at: https://journals.sagepub.com/doi/full/10.1177/0003122416687318 (Accessed: 26 March 2026).

  • When the Body Speaks What the Mind Cannot: The Psychoanalysis of Conversion Symptoms

    When the Body Speaks What the Mind Cannot: The Psychoanalysis of Conversion Symptoms

    As someone who has lived with complex mental health challenges and has spent years studying the intricate dialogue between mind and body, I am continually drawn to one of the most fascinating concepts in classical psychoanalysis: conversion symptoms.

    Advertisements

    Conversion symptoms occur when psychological distress or unconscious conflict is transformed into physical symptoms without any identifiable organic cause. Classic examples include sudden paralysis, blindness, seizures, loss of voice (aphonia), or glove anaesthesia (numbness in the hands that does not follow neurological distribution). These symptoms are real — the person genuinely cannot move a limb or see — yet medical investigations repeatedly find no structural damage or disease. In psychoanalytic terms, the symptom is not random; it carries symbolic meaning and serves a psychological purpose.

    The concept was central to the birth of psychoanalysis. In Studies on Hysteria (1895), Josef Breuer and Sigmund Freud introduced the revolutionary idea that hysterical symptoms were not signs of neurological disease or moral weakness, but expressions of repressed psychological material. They proposed that an intolerable idea or traumatic memory is pushed out of conscious awareness through repression. The emotional energy attached to that repressed material does not disappear; instead, it is “converted” into a bodily symptom. This process provides primary gain (relief from unbearable anxiety) and often secondary gain (attention, care, or avoidance of responsibility) (Freud and Breuer, 1895) .

    Freud later refined the theory, emphasising the role of unconscious sexual conflicts. A symptom, he argued, represents a compromise formation: it simultaneously expresses a forbidden wish and punishes the individual for having that wish. For example, a young woman who develops paralysis in her legs might unconsciously be expressing both a desire to run away from a distressing family situation and guilt for that desire. The symptom allows the conflict to be expressed without the person having to consciously acknowledge it.

    From a modern perspective, conversion symptoms are understood as a form of functional neurological disorder (FND). Neuroimaging studies have shown altered connectivity between emotion-processing areas (such as the amygdala and insula) and motor or sensory regions. This supports the psychoanalytic idea that psychological distress can genuinely disrupt bodily function without structural damage (Vuilleumier, 2014).

    Conversion symptoms are more common than many realise. They frequently appear in individuals with histories of trauma, insecure attachment, or difficulty identifying and expressing emotions (alexithymia). In forensic settings, they can sometimes be mistaken for malingering, though genuine conversion symptoms involve no conscious intent to deceive. The symptom is produced unconsciously as a defence mechanism.

    Treatment in the classical psychoanalytic tradition focuses on uncovering the repressed conflict through free association, dream analysis, and interpretation of transference. The goal is not simply to remove the symptom but to help the person understand its meaning and integrate the previously dissociated material. Modern approaches often combine psychodynamic insight with cognitive-behavioural techniques, physiotherapy, and sometimes medication for co-occurring anxiety or depression.

    Importantly, conversion symptoms should never be dismissed as “all in the head.” They represent real suffering and deserve respectful, multidisciplinary care. Labelling someone as “hysterical” in the old pejorative sense can cause profound harm and deepen shame. Contemporary clinicians emphasise validation of the distress while gently exploring its psychological roots.

    In my own reflective work, I have seen how the body can become a canvas for unprocessed emotions. When words fail, the body speaks — sometimes through pain, sometimes through paralysis, sometimes through inexplicable fatigue. Recognising conversion symptoms as meaningful communications rather than random malfunctions can open the door to deeper healing.

    In conclusion, conversion symptoms in psychoanalysis reveal the profound intelligence of the unconscious mind. They show us that the body and mind are not separate entities but deeply intertwined. By listening carefully to what the symptom is trying to say, we move from judgment to understanding, from symptom management to genuine psychological integration. In a world that often demands we ignore our inner world, the study of conversion reminds us that the body will always find a way to speak the truth the mind tries to silence.

    References

    Freud, S. and Breuer, J. (1895) Studies on hysteria. Standard Edition, Vol. 2. London: Hogarth Press. Available at: https://www.penguinrandomhouse.com/books/264434/the-divided-self-by-r-d-laing/ (Accessed: 26 March 2026).

    Vuilleumier, P. (2014) ‘Brain circuits implicated in psychogenic paralysis in conversion disorders and hypnosis’, Neurophysiologie Clinique, 44(4), pp. 323–337. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141772/ (Accessed: 26 March 2026).